Seagen
SGEN
#546
Rank
S$55.94 B
Marketcap
S$296.55
Share price
-0.07%
Change (1 day)
63.61%
Change (1 year)

Seagen (SGEN) - Total liabilities

Total liabilities on the balance sheet as of September 2023 : S$1.40 Billion

According to Seagen 's latest financial reports the company's total liabilities are S$1.40 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Seagen - Total liabilities on balance sheet (from 2001 to 2023)

Total liabilities by year

Year Total liabilities Change
2022-12-31S$1.16 B31.93%
2021-12-31S$0.88 B30.42%
2020-12-31S$0.67 B52.68%
2019-12-31S$0.44 B41.79%
2018-12-31S$0.31 B16.93%
2017-12-31S$0.26 B-9.36%
2016-12-31S$0.29 B-0.07%
2015-12-31S$0.29 B-9.75%
2014-12-31S$0.32 B2%
2013-12-31S$0.32 B7.17%
2012-12-31S$0.29 B12.23%
2011-12-31S$0.26 B23.19%
2010-12-31S$0.21 B-15.16%
2009-12-31S$0.25 B64.49%
2008-12-31S$0.15 B14.26%
2007-12-31S$0.13 B837.78%
2006-12-31S$14.5 M-40.16%
2005-12-31S$24.24 M-2.72%
2004-12-31S$24.92 M105.99%
2003-12-31S$12.09 M19.51%
2002-12-31S$10.12 M132%
2001-12-31S$4.36 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
ImmunoGen
IMGN
S$0.33 B-75.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
S$14.26 B 914.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
S$64.92 M-95.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
S$0.10 B-92.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
S$149.91 B 10,569.01%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
S$79.45 B 5,554.38%๐Ÿ‡ฌ๐Ÿ‡ง UK
AbbVie
ABBV
S$176.96 B 12,493.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
S$101.49 B 7,123.30%๐Ÿ‡บ๐Ÿ‡ธ USA